US-listed life sciences and diagnostics conglomerate that runs a portfolio of science and technology businesses using the Danaher Business System.
danaher.comLegal name
Danaher CorporationCEO
Rainer M. Blair
Chairman
Steven M. Rales
Founded
1984
Employees
~63,000 (2024)
Industry
Life sciences and diagnostics
Revenue (FY2025)
US$24.57 billionMarket Cap
~US$125.8 billion (Jul 2026)
Listed on
NYSE: DHR
Headquarters
Washington, D.C., US
Danaher Corporation is a US life sciences and diagnostics conglomerate headquartered in Washington, D.C. Founded in 1984 and listed on the New York Stock Exchange under the ticker DHR, the company runs a group of science and technology businesses spanning biotechnology, life sciences, and diagnostics. It employs roughly 63,000 people (2024) across about 700 locations in some 50 countries.
The company is led by President and Chief Executive Officer Rainer M. Blair. Brothers Steven M. Rales and Mitchell P. Rales, who built the company through the Danaher Business System of acquisitions and continuous improvement, serve as Chairman of the Board and Chairman of the Executive Committee. Matthew Gugino became Chief Financial Officer effective February 28, 2026, succeeding Matt McGrew, who had held the role since January 2019.
Danaher reported revenue of about US$24.57 billion for fiscal 2025 and carried a market capitalization near US$125.8 billion as of July 2026. In India the company runs a development center in Bengaluru with over 300 software engineers supporting many of its operating companies, along with a commercial office in Mumbai. Its shares trade on the S&P 500 and NYSE.
President and Chief Executive Officer
Chief Financial Officer
Chairman of the Board
Chairman of the Executive Committee
Interview experience
8/10
Interview difficulty
Medium
Interview process length
About a week
Practice real Danaher questions and get instant feedback before the real thing.
Q: Minimum Window Substring
A: Use a sliding window with two pointers and a count map of the target characters. Expand the right pointer until every needed character is covered, then shrink from the left to record the smallest valid window.
Q: Copy List with Random Pointer
A: Either use a hash map from each original node to its clone, or interleave copied nodes next to originals so random pointers can be wired in one pass, then split the two lists.
Q: Rotate Image
A: Rotate the matrix in place by first transposing it (swap across the diagonal), then reversing each row. This gives a 90 degree clockwise rotation without extra space.
Q: Group Anagrams
A: Group strings by a canonical key. Sort each string's characters, or use a 26 letter count signature, then bucket words that share the same key in a hash map.
Practice real Danaher questions and get instant feedback before the real thing.
Reported average
₹15,50,240/yr
3 salaries Salaries submitted
Reported average
₹13,27,724/yr
3 salaries Salaries submitted
Reported average
$155,402/yr
4 salaries Salaries submitted
Reported average
$82,012/yr
2 salaries Salaries submitted
Reported average
$254,560/yr
1 salary Salaries submitted
Reported average
$223,624/yr
1 salary Salaries submitted
Compare offers, benchmark your role, and see what similar candidates earn.
Bengaluru, Karnataka, India • Full-time, On-site
Bengaluru East, Karnataka, India • Full-time, On-site
Bengaluru, Karnataka, India • Full-time, On-site
Bengaluru East, Karnataka, India • Full-time
Bengaluru East, Karnataka, India • Full-time
Bengaluru East, Karnataka, India • Full-time
Tailor your resume to any Danaher role and get past the screen faster.
July 21, 2026
Danaher reports second quarter 2026 results
Danaher posted Q2 2026 revenue of $6.3 billion, up 5.5% year over year, with net earnings of $870 million ($1.23 diluted EPS) and adjusted diluted EPS of $1.94, up 8.0%. It raised full-year adjusted EPS guidance to $8.45 to $8.60, citing the earlier than expected close of the Masimo acquisition.
#earnings #Q22026 #DHR
View postJuly 14, 2026
Leica Biosystems to acquire StatLab
Danaher's Leica Biosystems agreed to acquire StatLab Medical Products, a maker of anatomical pathology consumables, from private equity owners. The deal is expected to close by the end of 2026, subject to regulatory approvals.
#acquisition #pathology #LeicaBiosystems
View postJune 10, 2026
Danaher completes acquisition of Masimo
Danaher closed its acquisition of Masimo Corporation, a specialty diagnostics provider focused on pulse oximetry and patient monitoring for acute care settings. Masimo was subsequently delisted from Nasdaq.
#acquisition #diagnostics #Masimo
View postApril 21, 2026
Danaher reports first quarter 2026 results
Danaher reported Q1 2026 revenue of $6.0 billion, up 3.5% year over year, with net earnings of $1.0 billion, diluted EPS of $1.45, and adjusted diluted EPS of $2.06, up 9.5%. Growth was led by biotechnology, offset by softer diagnostics.
#earnings #Q12026 #DHR
View postFebruary 16, 2026
Danaher agrees to acquire Masimo
Danaher entered a definitive agreement to acquire Masimo at $180.00 per share in cash, a total enterprise value of about $9.9 billion, expanding its diagnostics and patient monitoring portfolio ahead of the June 2026 close.
#acquisition #diagnostics #Masimo
View postRainer M. Blair is the President and Chief Executive Officer of Danaher Corporation.
